Ausgabe 11/2020
Inhalt (8 Artikel)
Targeting Inflammation to Reduce Residual Cardiovascular Risk
Oluremi N. Ajala, Brendan M. Everett
Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia
Sergei N. Pokrovsky, Olga I. Afanasieva, Marat V. Ezhov
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
Peter E. Penson, Maciej Banach
The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia
Jing Pang, Dick C. Chan, Gerald F. Watts
Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment
Antonio Gallo, Sophie Béliard, Laura D’Erasmo, Eric Bruckert
Gender Differences in Residual Risk Factors for Major Adverse Cardiovascular Events Following ACS and How to Bridge the Gap
Olivia Manfrini, Edina Cenko, Raffaele Bugiardini
Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve
Olga Gursky